Evidence map›Paper›PMID 32210603›Full record

ArticleClinical, cosmetic and investigational dermatology2020

Clinical Assessment of New Topical Cream Containing Two Essential Oils Combined with Tretinoin in the Treatment of Acne.

Vittorio Mazzarello, Elisabetta Gavini, Giovanna Rassu, Matthew Gavino Donadu, Donatella Usai, Gabriella Piu, Valeria Pomponi, Federica Sucato, Stefania Zanetti, Maria Antonia Montesu

Open access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Cutaneous Polymeric-Micelles-Based Hydrogel ContainingPharmaceuticals (Basel, Switzerland) · 2023
    Article
  6. Synergistic Antibacterial Effect of Ethyl Acetate Fraction ofAdvances in pharmacological and pharmaceutical sciences · 2023
    Article
  7. Review
  8. An Up-To-Date Review Regarding Cutaneous Benefits ofAntibiotics (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. An Overview of the Biological Activity of Pyrrolo[3,4-Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  17. A Unique Acylated Flavonol Glycoside fromAntioxidants (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Vittorio MazzarelloSkinlab, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.ORCID 0000-0002-9713-3306
Elisabetta GaviniDepartmentof Chemistry and Pharmacy, University of Sassari, Sassari, Italy.ORCID 0000-0002-0499-9419
Giovanna RassuDepartmentof Chemistry and Pharmacy, University of Sassari, Sassari, Italy.ORCID 0000-0001-6268-8179
Matthew Gavino DonaduSkinlab, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.ORCID 0000-0001-7681-6194
Donatella UsaiSkinlab, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Gabriella PiuSkinlab, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Valeria PomponiSkinlab, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Federica SucatoDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Stefania ZanettiSkinlab, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Maria Antonia MontesuDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
University of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcne is a frequent adolescent disease characterized by inflammatory and non-inflammatory lesions whose topical treatment very often presents adverse phenomena such as irritation or resistance to antibiotics that reduce the patient's compliance. The purpose of this study is to compare a commercial product (Acnatac gel) based on clindamycin-tretinoin (CTG) with a galenic compound containing 2 essential oils (

methodsSixty volunteers were randomly divided into an A group using MOTC and a B group, as a positive control, using CTG. The effectiveness was assessed with non-invasive skin analysis (Sebumeter, pH meter, Tewameter and Mexameter) and the counts of the number of lesions, after 15 and 30 days.

resultsIn both groups, there is a worsening of transepidermal water loss (TEWL) due to tretinoin. MOTC has improved, starting from 15 days of treatment, the papular erythema (p = 0.0329 vs CTG) and has reduced at all times even the rashes of retinoids present in the healthy perilesional skin (p = 0.0329 and p = 0.0017, respectively, at 15 and 30 days).

conclusionMOTC has shown, compared to Acnatac, to have anti-acne efficacy and to possess an anti-inflammatory activity, due to essential oils, able to reduce in vivo erythematous lesions and those induced by retinoids.

Indexed as

acneessential oilsnon-invasive skin analysis

Identifiers

PMID32210603
PMCPMC7073433
OpenAlexW3012095658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.